Novartis India

28
Strong Sell
  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE234A01025
  • NSEID: NOVARTIND
  • BSEID: 500672
INR
921.00
-13.2 (-1.41%)
BSENSE

Mar 23

BSE+NSE Vol: 32.31 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2025 is 6.33% vs -11.53% in Mar 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2025 is 40.09% vs 0.28% in Mar 2024

stock-summary

Interest

YoY Growth in year ended Mar 2025 is -48.32% vs -14.86% in Mar 2024

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2025 is 18.44% vs -17.58% in Mar 2024

Compare Profit and Loss Results of Novartis India
Markets Mojo
Figures in Cr
standalone - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
356.00
399.00
-43.00
-10.78%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
356.00
399.00
-43.00
-10.78%
Expenditure (Ex Depriciation)
Stock Adjustments
3.00
14.00
-11.00
-78.57%
Raw Materials Consumed
199.00
117.00
82.00
70.09%
Power & Fuel Cost
0.00
31.00
-31.00
-100.00%
Employee Cost
18.00
90.00
-72.00
-80.00%
Operating Expenses
8.00
21.00
-13.00
-61.90%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
10.00
5.00
5.00
100.00%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
9.00
2.00
7.00
350.00%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
264.00
328.00
-64.00
-19.51%
Operating Profit (PBDIT) excl Other Income
91.00
71.00
20.00
28.17%
Other Income
41.00
32.00
9.00
28.12%
Operating Profit (PBDIT)
133.00
104.00
29.00
27.88%
Interest
0.00
70.00
-70.00
-100.00%
Profit before Depriciation and Tax
132.00
34.00
98.00
288.24%
Depreciation
2.00
65.00
-63.00
-96.92%
Profit Before Taxation & Exceptional Items
130.00
-30.00
160.00
533.33%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
130.00
-30.00
160.00
533.33%
Provision for Tax
29.00
-20.00
49.00
245.00%
Profit After Tax
100.00
-9.00
109.00
1,211.11%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
728.00
-310.00
1,038.00
334.84%
Profit Available for appropriations
829.00
-320.00
1,149.00
359.06%
Appropriations
829.00
-320.00
1,149.00
359.06%
Equity Dividend (%)
500%
0%
500.00
Earnings Per Share
40.87
-0.63
41.50
6,587.30%
Profit And Loss - Net Sales
Net Sales 356.27 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 6.33% vs -11.53% in Mar 2024

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 91.42 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 40.09% vs 0.28% in Mar 2024

Profit And Loss - Interest
Interest 0.77 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -48.32% vs -14.86% in Mar 2024

Profit And Loss - Profit After Tax
Profit After Tax 100.90 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 18.44% vs -17.58% in Mar 2024